Exploring the prognosis value, immune correlation, and drug responsiveness prediction of homeobox C6 (HOXC6) in lung adenocarcinoma
Taken together, there is a great potential for HOXC6 to become a prognosis biomarker and contribute to develop treatment strategies for LUAD patients. Further mechanism exploration and drug development for HOXC6 are needed.
Authors
- Huajian Peng (ORCID: https://orcid.org/0000-0001-6423-3581)
- Mei Xin (ORCID: https://orcid.org/0000-0002-5732-7501)
- Linbo Zhang (ORCID: https://orcid.org/0000-0002-6771-5727)
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1007/s12672-024-01273-w
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.84